0001104659-23-081725.txt : 20230717
0001104659-23-081725.hdr.sgml : 20230717
20230717185011
ACCESSION NUMBER: 0001104659-23-081725
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230713
FILED AS OF DATE: 20230717
DATE AS OF CHANGE: 20230717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Faulkner Robert C.
CENTRAL INDEX KEY: 0001831991
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40890
FILM NUMBER: 231092621
MAIL ADDRESS:
STREET 1: C/O REDMILE GROUP
STREET 2: ONE LETTERMAN DRIVE, BUILDING D, SUITE D
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Augmedix, Inc.
CENTRAL INDEX KEY: 0001769804
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 833299164
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 SUTTER STREET, SUITE 1300
CITY: SAN FRANCISC
STATE: CA
ZIP: 94104
BUSINESS PHONE: 561-989-2208
MAIL ADDRESS:
STREET 1: 111 SUTTER STREET, SUITE 1300
CITY: SAN FRANCISC
STATE: CA
ZIP: 94104
FORMER COMPANY:
FORMER CONFORMED NAME: Malo Holdings Corp
DATE OF NAME CHANGE: 20190305
4
1
tm2321393-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-07-13
0
0001769804
Augmedix, Inc.
AUGX
0001831991
Faulkner Robert C.
C/O REDMILE GROUP, LLC ONE LETTERMAN
DRIVE, BUILDING D SUITE D3-300
SAN FRANCISCO
CA
94129
1
0
0
0
0
Common Stock
2023-07-13
4
A
0
21598
0.00
A
21598
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The reported securities will vest in full on the one-year anniversary of the grant date, subject to Mr. Faulkner's continued service on the Issuer's board through the vesting date or the earlier occurrence of a "corporate transaction" (as defined in the Issuer's 2020 Equity Incentive Plan). As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.
The securities were granted to Mr. Faulkner in connection with his service as a member of the Board of Directors of the Issuer. Mr. Faulkner, a managing director of Redmile Group, LLC ("Redmile"), was elected to the board of the Issuer as a representative of Redmile and its affiliates. Pursuant to the policies of Redmile, Mr. Faulkner holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Faulkner disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Faulkner is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
The securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Mr. Faulkner was elected to the board of directors of the Issuer as a representative of Redmile and its affiliates. As a result, Redmile and Mr. Green are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
/s/ Robert C. Faulkner
2023-07-17